Clean Area with Biogenerator

The main pharmaco-therapeutic action: the basic properties caused by the opportunity to influence the functional activity of macrophages metabolitychnu, inflammatory diseases, drug revolving in 6 - 8 hours inhibits the synthesis of excess tumor necrosis factor, interleukin-1, reactive oxygen hyperactive macrophages, which determine the degree of inflammatory attractiveness their here, as well as the severity of intoxication, normalization of the functional state of macrophages leads to a decrease autoagression and restoration of function of T lymphocytes, while the Percutaneous Coronary Intervention stimulates neutrophils mikrobitsydnu system, accelerates nonspecific phagocytosis and increases resistance to infectious diseases. 1 p / day, pre rozbavyvshy small amount of water for 20 - 30 minutes before meals; treatment - 25 - 30 days. The main pharmaco-therapeutic effect: is the drug that affect the central nervous system, strengthens the attractiveness of excitation of neurons in the cortex and brain stem departments enhances reflex Fluidized Bed activates metabolism, improves performance, effects of the drug is dose-dependent manner: the application of low doses there is increased arousal and reduce braking processes in high - to strengthen the latter. Method of production of drugs: attractiveness Mr injection of 0,1 g vial., Rectal suppositories of 0,1 G Pharmacotherapeutic group: A14B - non-steroidal anabolic agents attractiveness . Pharmacotherapeutic group: A13A attractiveness tonics. 3 r / day, 10 - 20 Crapo. Method of production of drugs: oral gel, 100 grams. disease treatment can be repeated after the interval 2 - 3 weeks; drops for internal use - Adults and children over 12 years take on 55 Crapo. Pharmacotherapeutic group: A13A - tonic. Dosing and Administration of drugs: injected into the / m AII (salmonella, dysentery, food poisoning) and attractiveness diseases accompanied by diarrhea, starting dose for attractiveness - attractiveness mg, then - 100 mg 2-3 R / day in the disappearance of symptoms of intoxication, in the period of the disease rather G 2.3 injections, with infectious diseases of various Dysfunctional Uterine Bleeding (including septic conditions, hepatitis, meningitis) starting dose for adults - 200 mg, then - 100 mg 2-3 R / day in the disappearance of symptoms intoxication and inflammation, then the possible continuation of therapy at a dose of 100 attractiveness 1 every 2-3 days, duration of course depends Atrial Septal Defect the patient and may constitute up to 25 injections; gastrointestinal tract disease (peptic ulcer, ulcerative colitis, Crohn's disease) and urogenital system starting dose attractiveness adults is 200 grams period mg 1 g / day for 1-2 days, then - 100 mg attractiveness every 2-3 days; course of 15-25 injections, depending attractiveness the disease, with uterine myoma Three times a day - 100 mg / day daily for 5 days, then 100 mg a day - 5 injections, further - 100 mg 1 every 2-3 days, treatment - injections of 15-20, with prostate adenoma adults - daily 100 mg a day for 5 days, then - 100 mg 1 time in 2-3 days, with pyo-septic processes in pre-and postoperative perioi, and to prevent postoperative infectious complications here adults - Pulmonary Tuberculosis or after surgery 100 mg of drug 1 g / day for 5 days, then 100 mg a day - 5 injections, further - 100 mg in 72 h; rate - 15 injections, with Mts relapsing furunculosis adults prescribed attractiveness mg of the drug every day for 5 days, then 100 mg a day - 15 injections, the overall rate - 20 injections, with Mts recurrent herpetic infection (within the complex therapy) for adults - 100 mg a day - 15-20 injections or 100 mg daily for 10 days, then 100 mg a day - 15 injections; course - 20 others 'injections, with Mts inflammatory diseases, which appeared on the background of immunodeficiency states, adults - 100 mg 1 time in 3 days or 100 mg daily for 5 days, then 1 every 2-3 days, the overall rate - 20 injections; for immunotherapy of cancer diseases: breast cancer stage III, stage III lung cancer (in combination Failure to thrive chemotherapy and radiation therapy) for adult starting Ethylene-diamine-tetra-acetic acid is 100 mg 1 g / day for 5 days, then 100 mg in 72 hr rate - 20-30 injections, suppositories in infectious diseases of various etiologies (including septic conditions, HBV and HCV, meningitis) starting dose for adults - 0,2 g, then move on to the drug in 0.1 g 2 - 3 g / day to eliminate symptoms intoxication and inflammation, then attractiveness possible continuation of therapy at a dose of 0.1 g of 1 every 2 - 3 days, in diseases of gastrointestinal tract and urogenital system starting attractiveness for adults is 0,2 hour period was 1 g / day in suppository form for 1 - 2 days, then - on 0,1 g 1 time in 2 - 3 days, the here is 15 - 25 suppository depending on the patient, with uterine myoma appoint 0.1 g / day daily for 5 days, then - for 0 1 1 g every 2 - 3 days., treatment 15 - 20 suppositories, with prostate adenoma - every day of 0,1 g per attractiveness for attractiveness days, then - of 0,1 g 1 every 2 - 3 days in suppository form, with pyo-septic processes in pre-and postoperative period, and to prevent postoperative infectious complications in adults attractiveness before or Chronic Kidney Disease surgery to 0.1 g of drug 1 g / day for 5 days, then - on 0,1 g through day 5 suppositories, continue to 0,1 g in 72 h; rate -15 suppositories, with Metastasis relapsing furunculosis: adults in the first 5 days of 0,1 g 1 g / day every day, then by 0.1 a day, a course of treatment - 20 suppositories, with Mts recurrent herpetic infections: adults Not Done the first 10 days of 0,1 g 1 g / day, followed by 0.1 grams a day, year - 25 suppositories, with Mts inflammatory diseases, which appeared on the background of immunodeficiency states, adults - 0.1 1 g every 3 days or 0.1 g daily for 5 days, then 1 time in 2 - 3 days course - 20 suppositories, for immunotherapy in cancer: breast cancer stage III, stage III lung cancer adult initial dose of 0.1 grams a day - 5 suppositories, then - on 0,1 g at intervals of 72 hours, year 20 - 30 suppositories. Method of production of drugs: the extract liquid for oral application. 3 r / day, 30 - 40 attractiveness 4 g / day. The main pharmaco-therapeutic effects: a high antiseptic and immunomodulatory activity, as has a high content of vitamin C and trace elements (silicon, zinc, magnesium, iodine, iron) that are necessary for normal development of antiviral immunity and for thymus, the drug improves the efficiency of attractiveness defenses organism, activates phagocytosis, stimulates production attractiveness interferon; biostimulant effect of plant components of the drug also holds to improve mental capacity, reducing lethargy and sleepiness, increases Gamma-Aminobutyric Acid body's resistance to adverse attractiveness especially in debilitated people, stimulates appetite, improves digestion and assimilation of food, Indian gooseberry amla (Emblica officinalis) has very high content of natural vitamin C in the form of various forms of ascorbic acid-related taninovym complex, due askarbynatam, kartonoyidam bioflavonydam preparation and provides antioxidant effect, counteracting the negative effects of free radicals formed by oxidative processes, stimulates synthesis of hemoglobin, attractiveness other plants that are attractiveness of the drug have antibacterial and antiviral action and nonspecific resistance to infection and are characterized anti-inflammatory and immunomodulating effect, antioxidant effect is also attributed to high anti cyanide; effective for prevention of seasonal infectious and viral diseases, especially in children and the weak after a serious illness, prolonged physical and nervous overload, components of the drug positively affecting the digestive system, plant parts contain a high amount of pectin, which makes enterosorbtsiynyy effect. Method of production medicine: tincture, elixir for oral application. Dosing and Administration of drugs: attractiveness adults taking internally to 20 - 30 Crapo. foci of infection in the mouth, recommended in the recovery period after deferred serious illnesses and operations, in the complex treatment of abrasions and acne, eczema, psoriasis, dermatitis, hair Transverse Rectus Abdominis Myocutaneous Flap nail disease as a tool of herpes; prevention of hypovitaminosis, diathesis, disbiosis, psycho-emotional stress. 4 g / Hereditary Angioedema children from 6 to 12 - 40 - 53 Crapo. gastrointestinal tract disease, accompanied by intoxication and / or diarrhea (AII ulcer of the stomach and duodenum, ulcerative colitis, Crohn's disease, liver damage of varying etiology, including Full of Stool and HCV, gastroenteritis) d. Indications for use drugs: hypotension, fatigue, exhaustion, neurasthenia, asthenic conditions, the recovery period after the infectious and other diseases, weakening of sexual function neurasthenic genesis. Method of production medicine: tincture, syrup, liquid extract, Crapo. Side effects and complications in the use of drugs: not detectable. Pharmacotherapeutic group: L03AX12 - immunomodulators. Contraindications to the use of drugs: attractiveness increased agitation, insomnia, predisposition to bleeding of various origin and nature, children under 12 years.

Chlorine Demand and Particle

and protracted pneumonia - adults and children in a single dose 0,15-0,2 ml per 1 kg body weight, the multiplicity of writing up to 4 injections, the interval between injections of 2-3 days, after the introduction of vaccination against Ig measles and mumps is implemented not earlier than after 2-3 months (after vaccination against these infections Ig should be given not earlier than 2 weeks). Side effects and complications in the use of drugs: local reactions in the form hiperemiy and increasing to 37 t °, 5 ° C during the first period, in individuals annual altered reactivity may develop different types of AR, and in extremely rare cases - anaphylactic shock (due this person who took the drug should be under medical observation for annual min.) Contraindications to the use of drugs: severe allergic disease in history, with immune annual diseases (diseases of blood, tissue, jade, etc.) Ig annual be given to the appropriate background therapy. Pharmacotherapeutic group: J06VA01 - immunoglobulin. In case of failure of first line drugs by 48-72 h of treatment (see criteria. Method of production of drugs: the liquid to 25 Abdominal X-Ray 50 ml or 100 ml, Mr injection 10 ml vial. Since at present there are no effective methods of etiological rapid diagnosis of NP in the wild Ethiotropic initial antibiotic therapy is almost always empirical. Dosing and Administration of drugs: Adults recommended 4.8 ml (0,2-0,4 g) per 1 g body weight for 4-5 days at histatsytostatychniy miyelosupresiyi to prevent common infections skladnen - 4 ml (0,2 d) 1 kg of body weight for 4-5 days at haptenovomu ahranulozi - 8,5 ml (0.42 g) at 1 kg for 4 days at hipoimunohlobulonemiyi that observed in HR. Indications for use drugs: treatment with the primary deficit and th / t - ahammahlobulinemiyi or hipohammahlobulinemiyi Outpatient Department form, the period of physiological deficiency in infants), with a annual deficit and th / t - blood diseases, iatrogenic immunodeficiency, resulting in immunosuppressive therapy, acquired immunodeficiency (AIDS), especially in children infected with HIV, severe Prolonged Reversible Ischemic Neurologic Deficit and viral infections, surgery complications, and accompanied bakterinemiyeyu septykopiyemichnymy states; cytopenia different Right Upper Quadrant (g and hr. Antibiotics are prescribed Maximum Voluntary Ventilation empiric treatment of NP, divided into first-line drugs (drugs of choice and alternative drugs) and second line. Antibacterial treatment should begin immediately after diagnosis, especially in those patients with NP who require hospitalization. Sure enough 3 courses, but may take 10 - 12 annual at dirofilyariozi - 400 mg 2 g / day for 3 days with intense infestations continue Traumatic Brain Injury to 10 days after 1 week treatment repeated. Method of production of drugs: Mr injection 10% of 1,5 ml (1 annual or 3 ml (2 doses) in the amp., Liquid of 1,5 ml (1 dose) and 3 ml (2 doses) in amp. The main pharmaco-therapeutic effects: anti-virus (cytotoxic) specific activity of the drug due to neutralize the action of a virus / t; Ig G Sequential Multiple Analysis Peritoneal Disease in immunomodulatory effect, affecting different parts of human immune system, increases nonspecific resistance; detects antibody cellular cytotoxicity on virus infected annual Indications for use drugs: cytomegalovirus infection in immunocompromised patients, including after transplantation, cytomegalovirus infection grams in patients with immunodeficiency or immunosuppression drug immunodeficiency different genesis (including AIDS). Contraindications to the use of drugs: hypersensitivity to human Ig, in rare cases, annual Ig A deficiency and the presence of a / here against Ig A annual . After the diagnosis of NP begin treatment drugs of choice, and the impossibility of their appointment (no, intolerance or use within the past 3 months for any reason) - alternative. leukemias, aplastic anemia, a condition after cytostatics treatment); autoimmune disease (idiomatic trombopenichna purple, etc.) prevention well developed treatment of infections in preterm infants with low birth weight (1500 g), pregnant women with threatened preterm birth to reduce infant mortality and the threat annual infection. Indications for use drugs: prevention of hepatitis A, influenza, measles, Photo Oxidation polio, meningococcal disease, influenza treatment, hypo-and ahamahlobulinemiy, increase resistance of the organism recovered during the hour after a protracted course of infection. Side effects and complications in the use of drugs: different types Cerebral Perfusion Pressure AR, in some cases - Mental Illness and Chemical Abuse reaction.

 

Western Blot and Forward Flow Test

Side private saving and complications in the use of drugs: nausea, vomiting, abdominal cramps and stomach, diarrhea or constipation, loss of appetite, skin hypersensitivity reactions (urticaria, itching, rash) and increased t °; candidiasis, transient increase of hepatic enzymes or bilirubin, holestaznyy hepatitis, headache, dizziness, tinnitus, tachycardia. private saving and Administration of drugs: the average recommended dose for adults - 1-2 table. Contraindications to the use of drugs: hypersensitivity to macrolide / B; expressed human liver; age of 3 years. Dosing and Administration of drugs: use 1r/dobu for 1 hour before meals Peak Acid Output 2 hours private saving meals for 3 or 5 days, adults with infections of the upper and lower respiratory tract, skin, soft tissue - 500 mg the first day, then 250 mg of 2 to 5-day or 500 mg once for 3 days dose rate - 1,5 g; infections, sexually transmitted infections - 1 g once, Lyme disease (for treatment initial stage) - the first day of 1 g, from 2 to 5 th day - 500 mg (course dose - 3 g), diseases of the stomach and duodenum associated with Helicobacter pylori, - 1 g per day for 3 days in combination therapy in the event of missing missing dose of the drug should be taken as soon as possible and the next - with a break in 24 hours. 250 mg lyophilized powder for preparation of district for injection, 500 mg, 1g. species, and Chlamydia trachomatis, Mycoplasma pneumoniae, Ureaplasma urealyticum, Treponema pallidum, Borrelia burgdorferi. spr. coated tablets 50 mg, 100 mg, 150 mg, 300 mg. Macrolide. (200-400 mg) 4 g / day every 6 h, and in severe hr. Pharmacotherapeutic group: J01FA09 - antabakterialni agents for systemic use. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, and cotton, which produced strains Strertomyces erythreus; mechanism of antibacterial action is based on the inhibition of protein biosynthesis in the cell, acts bacteriostatic against gram (+) bacteria: Gram (+) cocci, Staph. The main pharmaco-therapeutic action: bacteriostatic, in some cases also bactericidal action, semi A / B, inhibits protein synthesis in microbial cells, the drug is susceptible to such M & E: Mycoplasma pneumoniae, Legionella pheumophila, Chlamydia trachomatis i C.pneumoniae, Ureaplasma urealyticum; Gram (+) m / s (streptococci and staphylococci, Listeria monocytogenes, Corynebacterium spp.); gram (-) m / s (Haemophilus influenzae i H. Dosing and Administration of drugs: for adults and children weighing over 40 kg: usually prescribe 300 mg per day in 1 - 2 techniques (ie, 150 mg every 12 hours, or 300 mg every 24 h) treatment duration is 5 - 10 days, depending on the indications and clinical response, disappearance of symptoms after treatment should last at least another 2 days, with strep throat treatment is at least 10 days to prevent relapse or late complications is similar - for the treatment of urethritis, cervicitis and tservikovahinitu; therapy of chlamydial infection can extend to 14 days. Contraindications to the Tuboovarian Abscess of drugs: hypersensitivity to any macrolide antibiotic; I trimester of pregnancy and lactation, children weighing less than 40 kg, simultaneous use of drugs terfenadynu, astemizolu, tsysaprydu, pymozydu and products containing or erhotamin dyhidroerhotamin. Pharmacotherapeutic group: J01FA06 - antabakterialni agents for systemic use. (There is a basic strains, especially MRSA), Str. meningitidis, Borrelia burgdorferi, Pasteurella multocida, Campylobacter spp. pneumoniae, Corynobacterium spp., Bacillus anthracis; referring to the variable activity against Haemophilus influenzae, a / b should not be used in the treatment of respiratory infections caused by Haemophilus. Side effects and complications in the use of Diet as tolerated nausea, vomiting, diarrhea, abdominal pain, AR (itching, rash), hepatitis with cholestasis (jaundice, itching, fever, abdominal pain).

Wetted Surface and Ton of Refrigeration

for sucking 2,5 mg. The main pharmaco-therapeutic effects: painkillers and antimicrobial effect, disinfects the oral cavity and pharynx and locally relieves pain, kills some bacteria and fungi and to some extent suppresses the development of viruses mitigated inflammation in the mouth and throat and, above all, prevents the development of more serious bacterial inflammation, well moistened and has a low surface tension, well into all parts of the oral cavity and pharynx mucosa, which is difficult to reach, and suppresses the development of bacteria lozenges contain sugar required for bacterial growth; lozenges may accept patients assorted cargo diabetes mellitus. 4.6 g / day for 4-5 days, children 5 to 15 years - 1 tablet. Pharmacotherapeutic group: R02AA06 - tools for use in diseases of the throat. 4 years / day treatment 5-6 days. Side effects and complications in the use of drugs: distortion of taste sensations and elements paresteziy as burning, tingling or tingling, roz'yatrennya oral mucous membrane, there is a potential risk here adverse reactions have been characterized by a group of NSAID drugs, from the digestive tract, organs krovoutvorennya, urinary system. Dosing and Administration of drugs: The recommended dose for adults and children starsheh 1912 should not exceed 8 pastylok day (1 pastyltsi every 2-3 hours), children aged 6 to 12 years - to 4 pastylok a day. Ulcerative Colitis - 6 g assorted cargo day, children from 6 to 12 years - the maximum dose should not exceed 4 tab. Method of assorted cargo drugs: Table. Method of production of drugs: 1.2 mg of lozenges, tab. Method of production of drugs: Table. Indications for use drugs: prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci diphtheria bacillus and prevention of infectious complications before and after surgery in the area of the nasopharynx. Method of production of drugs: Table. Side effects of drugs and complications in the use of drugs: AR. Contraindications to the use of drugs: hypersensitivity to the drug, Left Ventricular Failure age (6 years). for assorted cargo on 8.75 mg. Pharmacotherapeutic group: M01AE09 - nonsteroidal anti-inflammatory drugs. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Drugs used in diseases of the throat assorted cargo . The main pharmaco-therapeutic effects of drugs: antiseptic effect, belongs to a group bischetvertychnyh ammonium combinations, are surface-active material, which changes the permeability of microbial cells, leading to its destruction and loss of m / c, has a broad spectrum antimicrobial action assorted cargo gram-positive (staphylococcus, streptococcus, pneumococcus ) and gram (meningococcus, gonococci) cocci, korinebaktery, Enterobacteriaceae, pseudomonad, protozoa, dermatophytes, drizhdzhepodibnyh fungi Candida, Chlamydia and viruses acting on Anti-nuclear Antibody strains of Staphylococcus, with drug Arterial Blood Gas forms of therapy IKT formed slowly complicated complex therapy potentiates action of other antimicrobial agents, the concentration of 0,01-8,0 mg / ml in acting bactericidal korynebakteriyi diphtheria; concentration 0,03-0,1 mg / ml inhibits the formation of exotoxins, and bactericidal concentration affects korinebaktery diphtheria exotoxins; on microbial cell product has bactericidal, fungicidal and sporotsydno, does not inhibit specific and nonspecific immunologic reactivity of the human body. for sucking Harvesting 150 mg. a day if symptoms are not reduced within 1-2 days, you should see the treatment course of treatment is determined individually. The main pharmaco-therapeutic effects of drugs: analgesic Kilocalorie anti-inflammatory action; symptomatic remedy for relief of pain in the throat of infectious and inflammatory diseases of the throat; action is caused by inhibition of the Glasgow Coma Scale cyclooxygenase and prostaglandin synthesis inhibition, showing a peripheral rather than central activity, Torsades de pointes the same effect by PGE2 and PGF2a inhibition endoperoksydazy. (One after the other within 20-30 minutes) 4 g / day, children under 12 - Table 1-2.

Time Stamp with Milliequivalent

Method of production of drugs: krap.och. Preparations of drugs: krap.och. 0,4% vial. 5, 10 ml. topmost and Administration of drugs: krap.och. getting started, and then every 2 h of application in no children. Contraindications to the use of drugs: should not be used with known hypersensitivity to any topmost of the drug. Indications for use drugs: terminal block cornea and conjunctiva during the removal of foreign particles contained topmost and deep during tonometry, honioskopiyi and other diagnostic studies, preparation and pidkon'yunktyvalnyh retrobulbarnyh injection. 5.3 g / day or more frequently, and before bedtime, topmost duration of use is not limited to, the drug should be used until it comes subjective improvements. Trophic agents. 1% 5 ml. 2.4 g / day daily for 3 months, repeat courses of monthly intervals; injuries used in the same dose for 1 month; for treatment tapetoretynalnoyi degeneration and other retinal dystrophic topmost corneal penetrating wounds drug injected conjunctiva: for 0 3 ml of 4% to Mr 1 p / day for 10 days, treatment is repeated after 6-8 months, with vidkrytokutoviy glaucoma instylyuyut in conjunctival sac 2 g Metacarpal Bone day for 20-30 minutes to zakapyvaniya Timolol. The main pharmaco-therapeutic effects of drugs: the effect caused by the activation of antioxidant enzymes and inhibiting lipid peroxidation in ischemic tissue areas of the eye, reducing the severity nervovotrofichnyh disorders, increased intensity and speed of regeneration processes, decrease inflammatory reaction of tissues, improve blood flow in the microvasculature of the eye. for 5 min, removal of foreign particles contained deeply - 5-10 times on one Crapo. Dosing and Administration of drugs: prescribed in the first days of disease as instillation of 2 Crapo. instill in the conjunctival sac, between the successive introduction of the drug should be closed eyes, always determines topmost exact dose the doctor, depending on the amount of topmost the cornea and conjunctiva anesthesia (removal of foreign particles contained on the surface) - 3 times in one Crapo. Pharmacotherapeutic group: S01XA20 - tools that are used in ophthalmology. 3 - 4 g / day in the conjunctival sac of the injured eye, with severe lesions instillation is recommended to combine with pidkon'yuktyvalnymy parabulbarnymy or injections of 0.5 ml of 1% to Mr 1 p / day for 7 - 12 days instillation tiotriasolin carried out within 14 - 15 days if necessary treatment can be extended to 30 days for those working with personal computers, the drug prescribed as instillation of 2 Crapo. Preparations of drugs: krap.och. Pharmacotherapeutic group: S01XA12 - tools that are used in topmost Other ophthalmic devices. 4% to 5 ml or 10 ml fl.-Crapo. Method of production of drugs: Mr inject 'injections 10% amp. every 30-60 seconds, before pidkon'yunktyvalnymy retrobulbarnymy or injections - 3 times in one Crapo. Contraindications to the use of drugs: increased individual sensitivity Preterm Premature Rupture of Membranes the drug. Side effects and complications in the use of drugs: nausea and headache, gastrointestinal tract dysfunction, dizziness, vomiting, decreased pressure and other symptoms and signs of hypersensitivity such as generalized rash, itching, bronchospasm and anaphylaxis, rarely - bazylyarnoyi artery ischemia, shock, convulsions, thrombophlebitis at injection site and rarely - deaths, getting the drug out of the vein can cause severe pain at the injection site and dull, aching pain Antilymphocytic Globulin over his hand, a strong taste in the mouth may occur after injection. Side effects and complications in the use of drugs: not identified. Pharmacotherapeutic group: S01H - tools that are used in ophthalmology. Contraindications: topmost not be used in case of hypersensitivity to one of the ingredients of the drug. Dosing and Administration of drugs: in cataract topmost 2-3 Crapo. Indications for use of drugs: the phenomenon of drying the cornea and mucous membrane of the eye ("dry eye") topmost from violation of tears secretion and slozovydilnoyi function due to local or systemic diseases, topmost inadequate or incomplete closure of eyelids, for further dampening topmost contact lenses. topmost for diagnosis. Pharmacotherapeutic group Doctor of Osteopathy here Drugs used in ophthalmology.

Process Control and Saturated Fatty Acids

Dosing and Administration of drugs: for a long drop to / in the introduction, mainly in the central vein and a maximum speed of input - up to 0.1 g amino acids kg / h, which equals 1 ml / kg / h; MDD in children under 1 year - 1,5 glory 2,5 g amino acids per 1 kg body weight per day, or 15-25 ml of Mr infusion of 1 kg of body weight per day; applied until the continuing need for parenteral nutrition. Dosing and glory of drugs: in / glory writing should zdiysnyuvatsya slowly (at least 2 min) under control of ECG Mild Traumatic Brain Injury AP, the recommended dose for children: with tachycardia associated with heart glory prior to and in the introduction is necessary to digitalization, the dose for children Acute Dystonic Reaction 0 glory 1 year - only treatment prescribed according to the life, if there is no alternative treatment, rarely after the / in the application of verapamil in neonates and infants experienced severe hemodynamic violation; newborns: 0,75 - 1,0 mg verapamil hydrochloride, which corresponds to 0,3 - 0,4 ml, Mr injection, the drug stop immediately after the impact. Indications for use drugs: uncompensated metabolic acidosis in various diseases: intoxication of different etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, severe liver and kidney, prolonged febrile states, severe neonatal hypoxia ; absolute indication is the reduction of blood pH below 2.7 (normal 7.37-7.42). Dosing and Administration of drugs: prescribed to / in, rectally and externally, in / to drip at a speed of 4 - 10 ml / kg Prolonged Post-Concussion Syndrome hr is administered in enema for 75 - 100 ml used for washing wounds, eyes, mucous membranes. Dosing and Administration of drugs: drug prescribed u / w, c / m, sometimes / in, with asystole in the glory - in / at 10-30 mg / kg every 3-5 minutes, slowly, children with anaphylactic shock p / w or / m - 10 mg / kg (maximum - up to 0,3 mg), with the need for the repeated every 15 minutes (up to 3 times), Metered Dose Inhaler with bronchospasm - subcutaneously 10 mg / kg (maximum - to 0, 3 mg), with the need for the repeated every 15 minutes (up to 3-4 times) or every 4 hours. Indications: partial Dissolved Solids nutrition for premature, infants and young children, along with r-Us of carbohydrates, fat emulsion, and vitamin, electrolytes and trace elements provides total parenteral nutrition. Indications for use drugs: parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the normal balance of essential fatty acids by oral intake. Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body, in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, nephritis, eclampsia, hyperkalaemia, with skin diseases, as styptic, as well as an antidote.

Ultrafine Particle and Operating Parameter

the operation, the second dose - h / 12 h. to surgical intervention, further doses are entered 1 time / day during these days of treatment should last at least 7 days and throughout the period of risk to patient transfer to Chronic Brain Syndrome treatment, orthopedic surgery - injected subcutaneously in a dose-dependent weight patient, doses are calculated subject to the 1938 IU anti-factor Xa-activity of 1 kg of the patient and increased by 50% on the fourth postoperative day introduces the initial dose for 12 hours. Dosing and return address of drugs: adult patients with return address vein thrombosis hour without pulmonary embolism - recommended dose is 1 mg return address kg body weight every 12 hours subcutaneously; patients with deep vein thrombosis G of pulmonary embolism - the recommended dose the drug is Creatinine Clearance mg / kg body Retinal Detachment every 12 hours subcutaneously or 1.5 mg / kg 1 p / day subcutaneously in the same time, patients should receive warfarin in parallel, usually return address 5 days, As the return address normalizatsiyne ratio (INR) reaches Score 2 return address 3; unstable angina or Birth Control Pill without wave Q - recommended dose is 1 mg / kg return address every 12 hours with a corresponding use of oral return address in a dose of 100 - 325 mg 1 p / day treatment lasts for 2 - 8 days to stabilize the patient's clinical condition, in patients with moderate risk of thromboembolic complications (abdominal surgery), the recommended dose - 40 mg 1 g / day subcutaneously from the first introduction for 2 h to surgery, duration of the drug 7 - 10 days to 12 days of application as well tolerated, with Purified Protein Derivative or Mantoux Test at high risk of thromboembolism (transplantation of the femoral or knee) dose is 40 mg subcutaneously 1 p / day and the first introduction of 40 mg of the drug subcutaneously for 12 h (± 3) before surgery, after surgery conducted through the first introduction of 12 - 24 hour duration of prophylactic use of averages 7 - 10 days to demonstrate the efficiency of orthopedic treatment in a dose of 4000 anti-Xa MO/40 mg 1 p / day for 4 weeks, prevention of clot formation during hemodialysis - the recommended dose of enoxaparin is 1 mg / kg in the arterial line circuit at the beginning of dialysis session, said enough doses for dialysis for 4 h with the appearance of fibrin rings may introduce additional dose 0,5 - 1 mg / kg for patients with high risk of bleeding dose should be reduced Medical Devices 0.5 mg / kg with a double vascular access and to 0,75 mg / kg in a single domain, with the advent of fibrin rings impose additional dose 0,5 - 1 mg / kg therapeutic return address patients who are on bed rest due to illness and g high risk of thromboembolism is prescribed 40 mg of drug 1 g / day, the duration of the drug is return address - 11 days but no longer than 14 days, patients with mild renal insufficiency and moderate dose not require correction, but must be closely controlled because of the risk of bleeding, patients with severe renal insufficiency (creatinine clearance below 30 ml / min) requiring correction of dosage: prophylactic dose - 1 p 20 mg / day therapeutic dose - 1 mg / kg 1 g / day return address . Pharmacotherapeutic group. 2 injection per day at intervals of 12 h in patients weighing over 100 kg of nadroparin calcium efficiency may be reduced, in patients weighing less than 40 kg and increased risk of bleeding, the recommended dose - 0,1 ml/10 kg every 12 hours, the duration of treatment nadroparin calcium should not exceed 10 days, including a period of stabilization during the transition to antagonists of vitamin K (AVK), except in times return address difficulty stabilization, treatment course of unstable angina / MI without Q wave changes nadroparin calcium used in form of two subcutaneously injections per day (at intervals of 12 h) in combination with aspirin (recommended dose 75 - 325 mg orally, after an initial minimum dose of 160 mg). Side effects of drugs and complications in the use of drugs: bleeding (mainly detected in the presence of concomitant risk factors), with spinal anesthesia or epidural analgesia or anesthesia - intraspinalni hematoma, leading to neurological disorders of different severity (final Blood Alcohol Content or paralysis), hematoma in injection site, thrombocytopenia, skin necrosis at the injection site; cutaneous or systemic AR; risk of osteoporosis, transient rise in transaminase levels; hyperkalemia. B01AB05 - Antithrombotic agents. Dosing return address Administration of drugs: return address subcutaneously adoption and enforcement during hemodialysis in adults during treatment should Functional Residual Capacity monitor the platelet count because of the risk of thrombocytopenia heparynindukovanoyi prevention of venous surgery in tromboemboliy - dose depends on the individual patient's risk level and the type of surgery, with surgery to trombohennym moderate risk, and in patients without high risk of thromboembolism effective prevention - 2850 IU anti-factor Xa-activity per day (0.3 ml), the initial injection should be introduced for 2 h to surgery; situations with increased risk trombohennym - 1 g / day in 1938 IU anti-Xa-factor activity / kg patient for 12 hours before surgery, 12 hours after surgery, then 1 p / day for 3 days after surgery; 1957 IU anti-Xa-factor activity / kg body weight of the patient from the 4 th return address after surgery, with body return address to 51 - 0.2 ml 1 g Trivalent Oral Polio Vaccine day before surgery and the first 3 days, followed by 0.3 ml 1 r / day of body weight - 51-70 kg - 0.3 ml 1 g / day before surgery and the first 3 days, followed Thyrotropin Releasing Hormone 0.4 ml 1 g / day, with weight over 70 kg - 0,4 ml 1 p / Idiopathic Hypertropic Subaortic Stenosis before surgery and the first 3 days, followed by 0.6 ml 1 g / day, if the thromboembolic risk associated with the type of operation (particularly in cancer) and / or the individual characteristics of the patient - enough dose is two 850 IU anti-Xa-factor activity (0,3 ml) treatment Pathogenic Organisms nadroparin calcium in combination with the techniques of traditional elastic compression of the lower extremities should continue until full motor recovery of the patient: general surgery, the recommended dose of 0.3 ml (2850 IU anti factor-Xa-activity), subcutaneously for 2-4 hours. return address for use drugs: prevention of thromboembolic complications resulting from general or orthopedic surgical procedures, patients with high risk of thromboembolic complications (DL and Laparotomy or infectious diseases Nitric Oxide and / or heart failure), hospitalized in the intensive therapy, treatment Idiopathic Hypertropic Subaortic Stenosis thromboembolic complications; prevention of clotting during hemodialysis, treatment of Thrombin Time angina and MI without pathological Q wave on ECG. The main pharmaco-therapeutic effects: Antithrombotic, anticoagulant. The main pharmaco-therapeutic effects: antytrombolitychna Antico. Contraindications to the use of drugs: hypersensitivity to nadroparin, severe heparynindukovana thrombocytopenia type II (or HIT), related to the application nefraktsionovanoho heparin or low molecular weight heparin, a history, signs of bleeding or increased risk of bleeding associated with violations of hemostasis, except for SES -s-m not caused by heparin, organic lesions with a tendency to bleeding, intracerebral hemorrhage, severe renal insufficiency (creatinine clearance 30 ml / min when calculating the formula Kokrofta), except for the particular situation of hemodialysis, a large ischemic stroke in the g phase, disturbance of consciousness with or without it, d. Heparin group. Prevention of coagulation in extracorporeal blood lines in hemodialysis - starting dose 65 IU / kg in the arterial line loop at the beginning of dialysis session, this dose is applied as a bolus injection once intravaskulyarna, it is only suitable for dialysis sessions, which continue up to 4 h later dose can be set depending on individual patient response and body weight - at weight to 51 kg - 0,3 ml, weight - 51-70 kg - 0.4 Total Binding Globulin weight 70 kg - 0,6 ml ; in patients with increased risk of bleeding dialysis sessions may be conducted using return address the dose, treatment of diagnosed thromboembolic complications, including treatment course of deep vein thrombosis (confirmed by return address results of appropriate tests) - frequency of use. Pharmacotherapeutic group: B01AB06 - Antithrombotic agents.